DE GIORGI, UGO FEDERICO FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 797
EU - Europa 237
AS - Asia 90
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.126
Nazione #
US - Stati Uniti d'America 797
PL - Polonia 104
IT - Italia 55
CN - Cina 53
DE - Germania 22
UA - Ucraina 20
VN - Vietnam 20
GB - Regno Unito 18
TR - Turchia 17
SE - Svezia 7
RU - Federazione Russa 5
FR - Francia 2
AT - Austria 1
BR - Brasile 1
EU - Europa 1
FI - Finlandia 1
MK - Macedonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.126
Città #
Fairfield 142
Warsaw 104
Woodbridge 84
Chandler 76
Ashburn 74
Houston 70
Cambridge 46
Seattle 45
Wilmington 39
Jacksonville 25
Dearborn 23
Princeton 23
Milan 21
Dong Ket 20
Ann Arbor 18
Izmir 16
Beijing 12
San Diego 12
Ferrara 10
Nanjing 8
Nanchang 6
Hebei 5
Bremen 4
Shanghai 4
Addison 3
Boardman 3
Bologna 3
Chicago 3
Jiaxing 3
London 3
Shenyang 3
Calderara di Reno 2
Cesena 2
Forlimpopoli 2
Hefei 2
Kunming 2
Norwalk 2
Araucária 1
Bratislava 1
Changsha 1
Chongqing 1
Edinburgh 1
Falls Church 1
Jinan 1
Jinhua 1
Kilburn 1
Lanzhou 1
Leawood 1
Limeil-brévannes 1
Melito Di Napoli 1
Monterotondo 1
Mountain View 1
Orange 1
Phoenix 1
Portomaggiore 1
Prescot 1
Prilep 1
Redmond 1
Redwood City 1
Santa Maria Capua Vetere 1
Segrate 1
Taiyuan 1
Tianjin 1
Vicenza 1
Vienna 1
Wandsworth 1
Washington 1
Wuhan 1
Totale 951
Nome #
Early use of abiraterone and radium-223 in metastatic prostate cancer 155
18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide 146
PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis 115
68 Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients 108
[177 Lu]-PSMA-617 for targeted prostate cancer treatment: a magic bullet? 96
68Ga-PSMA-PET: added value and future applications in comparison to the current use of choline-PET and mpMRI in the workup of prostate cancer 73
Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer 69
Testicular Microlithiasis and Testicular Germ Cell Tumours: a seven year retrospective study 54
Erratum to: 18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide [Eur J Nucl Med Mol Imaging, DOI 10.1007/s00259-015-3042-5] 53
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer 46
Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review 43
Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients 39
Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide 35
CAR-T cell therapy: A potential new strategy against prostate cancer 33
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell transplantation for high-risk breast cancer: results from the italian National Registry 28
Targeted radioactive therapy for prostate cancer 19
Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial 18
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients 17
Spotlight on PSMA as a new theranostic biomarker for bladder cancer 16
Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome 15
Post-traumatic stress symptoms in long-term disease-free cancer survivors and their family caregivers 13
Totale 1.191
Categoria #
all - tutte 7.380
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.380


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201972 0 0 0 0 0 0 0 0 0 0 32 40
2019/2020319 39 12 14 41 28 38 37 33 35 19 14 9
2020/2021290 10 9 10 9 26 67 21 35 17 41 17 28
2021/2022169 13 8 4 3 4 12 18 35 8 14 15 35
2022/2023187 22 5 23 6 26 30 18 11 21 1 17 7
2023/202448 15 5 5 3 7 3 1 5 0 1 3 0
Totale 1.191